Taming the sinister side of BMT: Dr. Jekyll and Mr. Hyde

Nature Medicine

Volumn 3, Issue 8, 1997, Pages 833-834

  Pardoll, Drew ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GANCICLOVIR; HLA ANTIGEN; MEMBRANE RECEPTOR; MINOR HISTOCOMPATIBILITY ANTIGEN; NEOMYCIN; PEPTIDE; THYMIDINE KINASE; VIRUS VECTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; DISEASE SEVERITY; DONOR; FLOW CYTOMETRY; GENE TRANSFER; GENETIC POLYMORPHISM; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOCYTE DEPLETION; PRIORITY JOURNAL; SHORT SURVEY; SUICIDE GENE; T LYMPHOCYTE;

BONE MARROW TRANSPLANTATION; CELL DEATH; CELL TRANSPLANTATION; GENE THERAPY; GRAFT VS HOST DISEASE; HERPESVIRUS 1, HUMAN; HUMANS; T-LYMPHOCYTES; THYMIDINE KINASE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030757408     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0897-833     Document Type: Short Survey

References (5)

1. Thomas, E. D. et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann. Intern. Med. 104, 155-163 (1986).
2. Bonini, C. et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724 (1997).
3. Wallny, H.-J & Rammense, H.-G Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature 343, 275-284 (1990).
4. Vogelsang, G. B. & Hess, A. D. Graft-versus-host disease: New directions for a persistent problem. Blood 84, 2061-2062 (1994).
5. Den Haan, J. M. Identification of graft-versus-host disease associated human minor histocompatibility antigen. Science 268, 1476-1480(1995).